Prevention and Management of Extravasation of Cytotoxic Drugs
- 1 April 1995
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 12 (4) , 245-255
- https://doi.org/10.2165/00002018-199512040-00004
Abstract
Extravasation of certain cytotoxic agents during peripheral intravenous administration may cause severe local injuries. Most extravasation can be prevented with the systematic implementation of...Keywords
This publication has 95 references indexed in Scilit:
- Reactivation of Thermal Burn by MethotrexateJNCI Journal of the National Cancer Institute, 1992
- The use of hyaluronidase in the treatment of intravenous extravasation injuries.1990
- EXPERIENCE WITH SUBCUTANEOUS INFUSION PORTS IN 300 PATIENTS1988
- Extravasation of dactinomycin, vincristine, and cisplatin: Studies in an animal modelMedical and Pediatric Oncology, 1985
- Failure of DMSO and vitamin E to prevent doxorubicin skin ulceration in the mouse.1983
- Full-thickness skin necrosis due to inadvertent interstitial infusion of cisplatin.1983
- Mitomycin C-induced skin ulceration remote from infusion site.1981
- EFFECT OF SODIUM THIOSULFATE ON CIS-DICHLORODIAMMINEPLATINUM(II) TOXICITY AND ANTI-TUMOR ACTIVITY IN L1210 LEUKEMIA1980
- Experimental and clinical studies of ulcers induced with adriamycin.1979
- Recall Injury from AdriamycinAnnals of Internal Medicine, 1975